Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lori Robertson

Nurse Practitioner, Family Chino Hills, CA Nurse Practitioner

NPI 1275539934 CMS profile 10850477

4200 Chino Hills Pkwy, Ste 905, Chino Hills, CA 91709

Open in the dashboard

General payments

$474,641

642 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lori Robertson of Chino Hills, CA is reported in the CMS Open Payments database as having received $474,641 across 642 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $141,425 147
2024 General $101,235 126
2023 General $89,617 115
2022 General $85,716 141
2021 General $56,647 113

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lori Robertson
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Lori Robertson were reported at $141,425. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Lori Robertson Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $56,647 $124 $35–$379 $132
2022 $85,716 $141 $44–$430 $149
2023 $89,617 $154 $49–$476 $160
2024 $101,235 $165 $51–$504 $164
2025 $141,425 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Galderma Laboratories, L.P. $465,663 592 payments
  2. Allergan Inc. $5,489 13 payments
  3. Musculoskeletal Transplant Foundation Inc. $1,397 8 payments
  4. Merz North America, Inc. $1,248 13 payments
  5. AbbVie, Inc. $756 14 payments
  6. Neuronetics, Inc. $70 1 payment
  7. Jazz Pharmaceuticals Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $373,853 139 payments
  2. Travel and Lodging $57,832 219 payments
  3. Consulting Fee $32,428 27 payments
  4. Food and Beverage $10,522 256 payments
  5. Education $6 1 payment
Products named General payments · program years 2021–2025
  1. BOTOX $5,730 18 payments
  2. DYSPORT $477 19 payments
  3. Xeomin Dermatology $414 5 payments
  4. DYSPORT $220 8 payments
  5. VENCLEXTA $209 6 payments
  6. Xeomin musculoskeletal $140 1 payment
  7. NEUROSTAR TMS THERAPY $70 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

642 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record